Texas researchers have shown that leptin could substitute for insulin to control blood sugar fluctuations in type 1 diabetes. The work has caught the attention of Amylin Pharmaceuticals, which is collaborating with the researchers to set up a Phase II trial of this therapeutic approach.
CITATION STYLE
Osherovich, L. (2010). Leptin instead of insulin. Science-Business EXchange, 3(10), 296–296. https://doi.org/10.1038/scibx.2010.296
Mendeley helps you to discover research relevant for your work.